Toward measuring effective treatment coverage: critical bottlenecks in quality- and user-adjusted coverage for major depressive disorder
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background: Major depressive disorder (MDD) is a leading cause of morbidity and mortality. Shortfalls in treatment quantity and quality are well-established, but the specific gaps in pharmacotherapy and psychotherapy are poorly understood. This paper analyzes the gap in treatment coverage for MDD and identifies critical bottlenecks. Methods: Seventeen surveys were conducted across 15 countries by the World Health Organization-World Mental Health Surveys Initiative. Of 35 012 respondents, 3341 met DSM-IV criteria for 12-month MDD. The following components of effective treatment coverage were analyzed: (a) any mental health service utilization; (b) adequate pharmacotherapy; (c) adequate psychotherapy; and (d) adequate severity-specific combination of both. Results: MDD prevalence was 4.8% (s.e., 0.2). A total of 41.8% (s.e., 1.1) received any mental health services, 23.2% (s.e., 1.5) of which was deemed effective. This 90% gap in effective treatment is due to lack of utilization (58%) and inadequate quality or adherence (32%). Critical bottlenecks are underutilization of psychotherapy (26 percentage-points reduction in coverage), underutilization of psychopharmacology (13-point reduction), inadequate physician monitoring (13-point reduction), and inadequate drug-type (10-point reduction). High-income countries double low-income countries in any mental health service utilization, adequate pharmacotherapy, adequate psychotherapy, and adequate combination of both. Severe cases are more likely than mild-moderate cases to receive either adequate pharmacotherapy or psychotherapy, but less likely to receive an adequate combination. Conclusions: Decision-makers need to increase the utilization and quality of pharmacotherapy and psychotherapy. Innovations such as telehealth for training and supervision plus non-specialist or community resources to deliver pharmacotherapy and psychotherapy could address these bottlenecks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Lancet Commission on global mental health and sustainable development
Patel, V., Saxena, S., Lund, C., Thornicroft, G., Baingana, F., Bolton, P., Chisholm, D., Collins, P. Y., Cooper, J. L., Eaton, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31612-x · Cited by 3,692
Self-citation(2004) · JAMA · doi:10.1001/jama.291.21.2581 · Cited by 3,448 · cited 4×
“The interview schedule used in WMH was the WHO Composite International Diagnostic Interview (CIDI) Version 3.0 (Kessler & Ustün, 2004), a fully-structured interview generating lifetime and 12-month prevalence estimates of common DSM-IV disorders that includes stringent protocols of translation, back-translation, adapt…”
InfluentialPrevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627 · cited 1×
“12-month MDD was defined as a major depressive episode among respondents who did not have a lifetime history of bipolar spectrum disorder (Merikangas et al., 2011).”
Self-citationEstimating the true global burden of mental illness
Vigo, D., Thornicroft, G., & Atun, R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00505-2 · Cited by 2,494
Self-citationWang, P. S., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, M. C., Borges, G., Bromet, E. J., Bruffaerts, R., de Girolamo, G., de Graaf, R., Gureje, O., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61414-7 · Cited by 1,655 · cited 4×
“Adequate medication control for patients taking psychotropic medications was defined as at least four visits with a physician (Wang et al., 2007).”
InfluentialSelf-citationScaling-up treatment of depression and anxiety: a global return on investment analysis
Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P., & Saxena, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30024-4 · Cited by 1,451
Self-citationSheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Goetzel, R. Z., Long, S. R., Ozminkowski, R. J., Hawkins, K., Wang, S., & Lynch, W. (2004) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000121151.40413.bd · Cited by 1,259
Disability weights for the Global Burden of Disease 2013 study
Salomon, J. A., Haagsma, J. A., Davis, A., de Noordhout, C. M., Polinder, S., Havelaar, A. H., Cassini, A., Devleesschauwer, B., Kretzschmar, M., Speybroeck, N., et al. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(15)00069-8 · Cited by 1,217 · cited 1×
“The disease burden caused by disorders affecting mental health is the most disabling of any disorder grouping for communities and individuals (Salomon et al., 2015; Vigo, Thornicroft, & Atun, 2016), and the associated economic burden results in the largest restriction of productivity of all…”
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181 · cited 2×
“These composite variables were based on a review of the April 2018 National Institute for Health and Care Excellence Guidelines (National Institute for Health and Care Excellence, 2009), the 2016 Canadian Network for Mood and Anxiety Treatments guidelines (Kennedy et al., 2016; Parikh et al., 2016), the 2010 American…”
Undertreatment of people with major depressive disorder in 21 countries
Thornicroft, G., Chatterji, S., Evans-Lacko, S., Gruber, M., Sampson, N., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Andrade, L., Borges, G., et al. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.188078 · Cited by 1,121 · cited 2×
“Yet an under-spending on mental disorders continues to exist relative to other classes of disorders (Alonso et al., 2018; Degenhardt et al., 2017; Thornicroft et al., 2017; Vigo, Kestel, Pendakur, Thornicroft, & Atun, 2019).”
InfluentialSelf-citationAlonso, J., Liu, Z., Evans-Lacko, S., Sadikova, E., Sampson, N., Chatterji, S., Abdulmalik, J., Aguilar-Gaxiola, S., Al-Hamzawi, A., Andrade, L. H., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22711 · Cited by 716 · cited 1×
“Yet an under-spending on mental disorders continues to exist relative to other classes of disorders (Alonso et al., 2018; Degenhardt et al., 2017; Thornicroft et al., 2017; Vigo, Kestel, Pendakur, Thornicroft, & Atun, 2019).”
Self-citationImproving access to psychological therapy: initial evaluation of two UK demonstration sites
Clark, D. M., Layard, R., Smithies, R., Richards, D. A., Suckling, R., & Wright, B. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.07.010 · Cited by 599 · cited 1×
“…of physician services and to scale up psychotherapeutic services have been successfully implemented in the UK and are currently under way in other jurisdictions such as France and Canada (Clark et al., 2018; Clark et al., 2009; British Columbia Ministry of Mental Health and Addictions, 2019).”
Joshi, R., Alim, M., Kengne, A. P., Jan, S., Maulik, P. K., Peiris, D., & Patel, A. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103754 · Cited by 589 · cited 2×
“Training community members and non-specialists, as well as leveraging telemedicine, have been posited as reasonable and feasible policies to expand capacity in low-income settings (Joshi et al., 2014; Shigekawa, Fix, Corbett, Roby, & Coffman, 2018).”
Parikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562 · cited 2×
“Cost-effective interventions to treat mental disorders have been tested in countries across income levels and are ready for global scaleup (Patel et al., 2016; Patel et al., 2018; Vigo, et al., 2019).”
Lasalvia, A., Zoppei, S., Van Bortel, T., Bonetto, C., Cristofalo, D., Wahlbeck, K., Bacle, S. V., Van Audenhove, C., van Weeghel, J., Reneses, B., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61379-8 · Cited by 445
Self-citationThe Current State Of Telehealth Evidence: A Rapid Review.
Shigekawa, E., Fix, M., Corbett, G., Roby, D. H., & Coffman, J. (2018) · Health Affairs · doi:10.1377/hlthaff.2018.05132 · Cited by 406
Degenhardt, L., Glantz, M., Evans‐Lacko, S., Sadikova, E., Sampson, N., Thornicroft, G., Aguilar‐Gaxiola, S., Al‐Hamzawi, A., Alonso, J., Helena Andrade, L., et al. (2017) · World Psychiatry · doi:10.1002/wps.20457 · Cited by 267 · cited 1×
“Yet an under-spending on mental disorders continues to exist relative to other classes of disorders (Alonso et al., 2018; Degenhardt et al., 2017; Thornicroft et al., 2017; Vigo, Kestel, Pendakur, Thornicroft, & Atun, 2019).”
Self-citationten Have, M., Nuyen, J., Beekman, A., & de Graaf, R. (2013) · Psychological Medicine · doi:10.1017/s0033291713000135 · Cited by 63
Cited by
Time for united action on depression: a Lancet–World Psychiatric Association Commission
Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02141-3 · Cited by 1,104
Self-citationMoitra, M., Santomauro, D., Collins, P. Y., Vos, T., Whiteford, H., Saxena, S., & Ferrari, A. J. (2022) · PLOS Medicine · doi:10.1371/journal.pmed.1003901 · Cited by 355
“While epidemiological surveys capturing data on service use for individuals with depressive disorders exist, efforts to assemble and critically evaluate the data for a representative global summary of treatment rates are outdated or do not capture all available information [13].”
BackgroundStein, D. J., Shoptaw, S. J., Vigo, D. V., Lund, C., Cuijpers, P., Bantjes, J., Sartorius, N., & Maj, M. (2022) · World Psychiatry · doi:10.1002/wps.20998 · Cited by 331
Self-citationLu, B., Lin, L., & Su, X. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.074 · Cited by 289
Estimating the global treatment rates for depression: a systematic review and meta-analysis
Mekonen, T., Chan, G. C. K., Connor, J. P., Hides, L., & Leung, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.038 · Cited by 137
Metadata
- Authors
- Vigo, D., Haro, J. M., Hwang, I., Aguilar-Gaxiola, S., Alonso, J., Borges, G., Bruffaerts, R., Caldas-de-Almeida, J. M., de Girolamo, G., Florescu, S., Gureje, O., Karam, E., Karam, G., Kovess-Masfety, V., Lee, S., Navarro-Mateu, F., Ojagbemi, A., Posada-Villa, J., Sampson, N. A., Scott, K., Stagnaro, J. C., ten Have, M., Viana, M. C., Wu, C.-S., Chatterji, S., Cuijpers, P., Thornicroft, G., & Kessler, R. C.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2020-10-20
- Volume
- 52
- Issue
- 10
- Pages
- 1948-1958
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W3092920753
- Cited by
- 60
- References
- 19
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.